The role of heparan sulfate in enhancing the chemotherapeutic response in triple-negative breast cancer

The role of heparan sulfate in enhancing the chemotherapeutic response in triple-negative breast cancer

Abstract Background Breast cancer, one of the most common forms of cancer, is associated with the highest cancer-related mortality among women worldwide. In comparison to other types of breast cancer, patients diagnosed with the triple-negative breast cancer (TNBC) subtype have the worst outcome bec...

Full description

Saved in:
Bibliographic Details
Main Authors: Jasmine M. Manouchehri, Jharna Datta, Lynn M. Marcho, Jesse J. Reardon, Daniel Stover, Robert Wesolowski, Uma Borate, Ting-Yuan David Cheng, Patrick M. Schnell, Bhuvaneswari Ramaswamy, Gina M. Sizemore, Mark P. Rubinstein, Mathew A. Cherian
Format: Article
Language:English
Published: BMC 2024-11-01
Series:Breast Cancer Research
Subjects:
ATP
Chemotherapy
Heparanase
Purinergic signaling
Breast cancer
Heparan sulfate
Online Access:https://doi.org/10.1186/s13058-024-01906-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13058-024-01906-6

Similar Items